Machado Mariana Verdelho, Diehl Anna Mae
Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, North Carolina; Gastroenterology Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal.
Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Gastroenterology. 2016 Jun;150(8):1769-77. doi: 10.1053/j.gastro.2016.02.066. Epub 2016 Feb 27.
Nonalcoholic steatohepatitis (NASH) is a necro-inflammatory response that ensues when hepatocytes are injured by lipids (lipotoxicity). NASH is a potential outcome of nonalcoholic fatty liver (NAFL), a condition that occurs when lipids accumulate in hepatocytes. NASH may be reversible, but it can also result in cirrhosis and primary liver cancer. We are beginning to learn about the mechanisms of progression of NAFL and NASH. NAFL does not inevitably lead to NASH because NAFL is a heterogeneous condition. This heterogeneity exists because different types of lipids with different cytotoxic potential accumulate in the NAFL, and individuals with NAFL differ in their ability to defend against lipotoxicity. There are no tests that reliably predict which patients with NAFL will develop lipotoxicity. However, NASH encompasses the spectrum of wound-healing responses induced by lipotoxic hepatocytes. Differences in these wound-healing responses among individuals determine whether lipotoxic livers regenerate, leading to stabilization or resolution of NASH, or develop progressive scarring, cirrhosis, and possibly liver cancer. We review concepts that are central to the pathogenesis of NASH.
非酒精性脂肪性肝炎(NASH)是一种坏死性炎症反应,当肝细胞因脂质损伤(脂毒性)而引发。NASH是非酒精性脂肪肝(NAFL)的一种潜在后果,NAFL是脂质在肝细胞中蓄积时出现的一种病症。NASH可能是可逆的,但也可能导致肝硬化和原发性肝癌。我们开始了解NAFL和NASH的进展机制。NAFL并非必然会发展为NASH,因为NAFL是一种异质性病症。这种异质性的存在是由于具有不同细胞毒性潜能的不同类型脂质在NAFL中蓄积,且NAFL患者抵御脂毒性的能力也存在差异。目前尚无可靠的检测方法能够预测哪些NAFL患者会发生脂毒性。然而,NASH涵盖了脂毒性肝细胞引发的一系列伤口愈合反应。个体之间这些伤口愈合反应的差异决定了脂毒性肝脏是再生,从而使NASH稳定或消退,还是发展为进行性瘢痕形成、肝硬化以及可能的肝癌。我们综述了NASH发病机制的核心概念。